Tag Archives: opioid

DOT Issues Final Rule to Add Semi-Synthetic Opioids to Drug Testing Panel to Combat Opioid Epidemic


Written By ESR News Blog Editor Thomas Ahearn

The U.S. Department of Transportation (DOT) has issued a final rule in the Federal Register that adds four semi-synthetic opioids – hydrocodone, oxycodone, hydromorphone, and oxymorphone – to its drug testing panel for DOT regulated industries, adds methylenedioxyamphetamine (MDA) as an initial test analyte, and removes the testing for methylenedioxyethylamphetaime (MDEA), according to a DOT press release. DOT regulated employers will be required to test for these opioids starting January 1, 2018. Continue reading

Drug Testing for Opioids Expected to Increase after President Trump Declares Opioid Crisis a National Public Health Emergency

Written By ESR News Blog Editor Thomas Ahearn

On October 26, 2017, President Donald Trump officially declared “the opioid crisis a national public health emergency under federal law” and directed “all executive agencies to use every appropriate emergency authority to fight the opioid crisis” during remarks in the East Room of the White House. Continue reading

Employers Need to Use Proper Drug Testing Panels to Fight Opioid Epidemic in Workplace


Written By ESR News Blog Editor Thomas Ahearn

Even with the dramatic rise in the use of opioids – which can include the illegal drug heroin and legally prescribed pain relievers such as OxyContin® and Vicodin® – some employers hoping to avoid hiring opioid-addicted workers through drug testing may not know the best type of drug test panel to use to uncover opioid abuse, according to an article from Talent Economy. Continue reading